Elanco, the maker of Interceptor® Plus (milbemycin oxime/praziquantel), develops and markets products to improve animal health in more than 75 countries. This global, innovation-driven company was established in 1954 as a division of Eli Lilly and Company. Today, Elanco Animal Health continues enhancing the human-animal bond by enabling veterinarians to help pets live longer, healthier, higher-quality lives.
At Elanco, we are committed to developing products that are safe for animals, the environment and the consumer. And you can get peace of mind from knowing that all our products conform to rigorous regulatory oversight and quality assurance systems that are built on consistency, dependability, accountability and traceability.